Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSStandard

ADENOSINE

ADENOSINE

Standard Dose
60MG/20ML (3MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview ADENOSINE is listed in Drugs@FDA under application 205331 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient ADENOSINE Form and strength SOLUTION;INTRAVENOUS - 60MG/20ML (3MG/ML) Sponsor EUGIA PHARMA Submission history Latest submission status date: 2017-11-02 00:00:00.

Structured Monograph

Clinical summary

Approval overview ADENOSINE is listed in Drugs@FDA under application 205331 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ADENOSINE Form and strength SOLUTION;INTRAVENOUS - 60MG/20ML (3MG/ML) Sponsor EUGIA PHARMA Submission history Latest submission status date: 2017-11-02 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.